Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy.

Sporadic inclusion body myositis (s-IBM) is a chronic inflammatory myopathy of unknown pathogenesis. The common findings of ragged red fibres, cytochrome c oxidase-negative fibres and multiple mitochondrial DNA deletions in the muscle of patients with s-IBM have suggested that a deficit of energy metabolism may be of pathogenic relevance. To test this hypothesis we used 31P magnetic resonance spectroscopy to assess in vivo skeletal muscle mitochondrial function in the calf muscles of 12 patients with definite s-IBM. Eleven patients showed multiple mitochondrial DNA deletions in skeletal muscle and 67% showed ragged red fibres and/or cytochrome c oxidase-negative fibres. T1-weighted MR images showed increased signal intensity in the calf muscle of all patients except one. The involvement of calf muscle was confirmed by 31P magnetic resonance spectroscopy of resting muscle, which disclosed abnormalities in metabolite ratios in all patients. However, muscle oxidative metabolism assessed during recovery from exercise was normal in patients with s-IBM, as maximum rates of mitochondrial ATP production and post-exercise ADP recovery rates were within the normal range in all cases. We conclude that muscle mitochondrial abnormalities are a secondary process and unlikely to play a significant role in the pathogenesis of s-IBM.

[1]  S. Dimauro,et al.  An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region , 1989, Nature.

[2]  D. Gadian,et al.  Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. , 1983, Molecular biology & medicine.

[3]  S. Dimauro,et al.  Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients , 1996, Annals of neurology.

[4]  G. Radda,et al.  Bioenergetics of skeletal muscle in mitochondrial myopathy , 1994, Journal of the Neurological Sciences.

[5]  A. Pestronk,et al.  Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. , 1997, Brain : a journal of neurology.

[6]  E. Holme,et al.  Mitochondrial DNA Deletions in Muscle Fibers in Inclusion Body Myositis , 1995, Journal of neuropathology and experimental neurology.

[7]  P. Matthews,et al.  metabolic recovery after exercise and the assessment of mitochondrial function in Vivo in human skeletal muscle by means of 31P NMR , 1984, Magnetic resonance in medicine.

[8]  Franca Podo,et al.  Magnetic resonance spectroscopy in biology and medicine : functional and pathological tissue characterization , 1992 .

[9]  B CHANCE,et al.  Respiratory enzymes in oxidative phosphorylation. III. The steady state. , 1955, The Journal of biological chemistry.

[10]  A. Eisen,et al.  Inclusion body myositis , 1978, Neurology.

[11]  M. Dalakas,et al.  Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis , 1997, Neurology.

[12]  J. Müller‐Höcker Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: An age-related alteration , 1990, Journal of the Neurological Sciences.

[13]  S. Dimauro,et al.  Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. , 1992, Biochimica et biophysica acta.

[14]  Simon C Watkins,et al.  A qualitative and quantitative study of the ultrastructure of regenerating muscle fibres in Duchenne muscular dystrophy and polymyositis , 1987, Journal of the Neurological Sciences.

[15]  G K Radda,et al.  Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle , 1993, NMR in biomedicine.

[16]  H A Krebs,et al.  Cytosolic phosphorylation potential. , 1979, The Journal of biological chemistry.

[17]  P. Matthews,et al.  In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondria1 disease , 1991, Neurology.

[18]  E. Holme,et al.  Mitochondrial DNA deletions in inclusion body myositis. , 1993, Brain : a journal of neurology.

[19]  J. Dambrosia,et al.  Treatment of inclusion-body myositis with IVIg , 1997, Neurology.

[20]  S. Carpenter,et al.  Pathology of Skeletal Muscle , 1984 .

[21]  S. Dimauro,et al.  Inclusion body myositis and myopathies , 1995, Annals of neurology.

[22]  P. M. Matthews,et al.  Short‐term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders , 1995, Neurology.

[23]  S. Welle,et al.  Ragged Red Fibers in Normal Aging and Inflammatory Myopathy , 1995, Annals of neurology.

[24]  S. Frostick,et al.  Cellular energetics of dystrophic muscle , 1993, Journal of the Neurological Sciences.

[25]  G Serratrice,et al.  31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies , 1992, Neurology.

[26]  M. Lazdunski,et al.  The regulation of the intracellular pH in cells from vertebrates. , 1988, European journal of biochemistry.

[27]  D. Arnold,et al.  Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy , 1985, Annals of neurology.

[28]  L. Salberg,et al.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) , 1994, Neurology.

[29]  J. Masdeu,et al.  Inclusion body myositis. A corticosteroid-resistant idiopathic inflammatory myopathy. , 1982, Archives of neurology.

[30]  J. Durnin,et al.  Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years , 1974, British Journal of Nutrition.

[31]  G. Radda,et al.  In vivo skeletal muscle mitochondrial function in Leber's hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy , 1997, Annals of neurology.

[32]  N. Bresolin,et al.  Leber's hereditary optic neuropathy , 1991, Neurology.

[33]  M. Dalakas,et al.  Inclusion Body Myositis , 1997, Neurology.

[34]  B CHANCE,et al.  Respiratory enzymes in oxidative phosphorylation. II. Difference spectra. , 1955, The Journal of biological chemistry.

[35]  C. Hengstenberg,et al.  Whole mitochondrial genome amplification reveals basal level multiple deletions in mtDNA of patients with dilated cardiomyopathy. , 1995, Biochemical and biophysical research communications.